Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication.

Luo T, Li J, Li L, Yang B, Liu C, Zheng Q, Jin B, Chen Z, Li K, Zhang X, Zhang J.

Thromb Res. 2013 Oct;132(4):427-32. doi: 10.1016/j.thromres.2013.08.005. Epub 2013 Aug 14.

PMID:
23998557
[PubMed - indexed for MEDLINE]
2.

Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.

Brevetti G, Perna S, Sabbá C, Martone VD, Condorelli M.

J Am Coll Cardiol. 1995 Nov 15;26(6):1411-6.

PMID:
7594063
[PubMed - indexed for MEDLINE]
Free Article
3.

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.

Hiatt WR, Regensteiner JG, Creager MA, Hirsch AT, Cooke JP, Olin JW, Gorbunov GN, Isner J, Lukjanov YV, Tsitsiashvili MS, Zabelskaya TF, Amato A.

Am J Med. 2001 Jun 1;110(8):616-22.

PMID:
11382369
[PubMed - indexed for MEDLINE]
4.

A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication.

Delaney CL, Spark JI, Thomas J, Wong YT, Chan LT, Miller MD.

Atherosclerosis. 2013 Jul;229(1):1-9. doi: 10.1016/j.atherosclerosis.2013.03.004. Epub 2013 Mar 15. Review.

PMID:
23557982
[PubMed - indexed for MEDLINE]
5.

L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial.

Goldenberg NA, Krantz MJ, Hiatt WR.

Vasc Med. 2012 Jun;17(3):145-54. doi: 10.1177/1358863X12442264.

PMID:
22615190
[PubMed - indexed for MEDLINE]
6.

Propionyl-L-Carnitine versus Pentoxifylline : Improvement in Walking Capacity in Patients with Intermittent Claudication.

Strano A.

Clin Drug Investig. 2002 Nov;22(Suppl 1):1-6. doi: 10.2165/00044011-200222001-00001.

PMID:
23315429
[PubMed]
7.

European multicenter study on propionyl-L-carnitine in intermittent claudication.

Brevetti G, Diehm C, Lambert D.

J Am Coll Cardiol. 1999 Nov 1;34(5):1618-24.

PMID:
10551714
[PubMed - indexed for MEDLINE]
8.

Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication.

Mohler ER 3rd, Gainer JL, Whitten K, Eraso LH, Thanaporn PK, Bauer T.

Vasc Med. 2011 Oct;16(5):346-53. doi: 10.1177/1358863X11422742.

PMID:
22003000
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication.

Brass EP, Cooper LT, Morgan RE, Hiatt WR.

J Vasc Surg. 2012 Feb;55(2):381-389.e1. doi: 10.1016/j.jvs.2011.09.004. Epub 2011 Nov 25.

PMID:
22119244
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease.

Hiatt WR, Creager MA, Amato A, Brass EP.

J Cardiopulm Rehabil Prev. 2011 Mar-Apr;31(2):125-32. doi: 10.1097/HCR.0b013e3181f1fd65.

PMID:
20861750
[PubMed - indexed for MEDLINE]
11.

Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.

Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG, Kupcinskas L, Lesniakowski K, Grinevich VB, Malecka-Panas E, Ardizzone S, D'Arienzo A, Valpiani D, Koch M, Denapiene G, Vago G, Fociani P, Zerbi P, Ceracchi M, Camerini R, Gasbarrini G.

Aliment Pharmacol Ther. 2011 Nov;34(9):1088-97. doi: 10.1111/j.1365-2036.2011.04844.x. Epub 2011 Sep 19.

PMID:
21929562
[PubMed - indexed for MEDLINE]
12.

A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.

Brass EP, Koster D, Hiatt WR, Amato A.

Vasc Med. 2013 Feb;18(1):3-12. doi: 10.1177/1358863X12467491. Epub 2013 Jan 15. Review.

PMID:
23321261
[PubMed - indexed for MEDLINE]
13.

Effect of propionyl-L-carnitine on quality of life in intermittent claudication.

Brevetti G, Perna S, Sabba C, Martone VD, Di Iorio A, Barletta G.

Am J Cardiol. 1997 Mar 15;79(6):777-80.

PMID:
9070558
[PubMed - indexed for MEDLINE]
14.

Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease.

Barker GA, Green S, Askew CD, Green AA, Walker PJ.

Med Sci Sports Exerc. 2001 Sep;33(9):1415-22.

PMID:
11528327
[PubMed - indexed for MEDLINE]
15.

Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication.

Lewis RJ, Connor JT, Teerlink JR, Murphy JR, Cooper LT, Hiatt WR, Brass EP.

Trials. 2011 May 25;12:134. doi: 10.1186/1745-6215-12-134.

PMID:
21612611
[PubMed - indexed for MEDLINE]
Free PMC Article
16.
17.

Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.

Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K.

Am Heart J. 2007 May;153(5):874-80.

PMID:
17452167
[PubMed - indexed for MEDLINE]
18.

Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease.

Hiatt WR, Hirsch AT, Creager MA, Rajagopalan S, Mohler ER, Ballantyne CM, Regensteiner JG, Treat-Jacobson D, Dale RA, Rooke T.

Vasc Med. 2010 Jun;15(3):171-9. doi: 10.1177/1358863X09360579. Epub 2010 Mar 8.

PMID:
20212073
[PubMed - indexed for MEDLINE]
19.

Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.

Riccioni C, Sarcinella R, Palermo G, Izzo A, Liguori M, Koverech A, Messano M, Virmani A.

Int Angiol. 2008 Jun;27(3):253-9.

PMID:
18506129
[PubMed - indexed for MEDLINE]
20.

Prostanoids for intermittent claudication.

Robertson L, Andras A.

Cochrane Database Syst Rev. 2013 Apr 30;4:CD000986. doi: 10.1002/14651858.CD000986.pub3. Review.

PMID:
23633305
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk